Table: Torii Pharmaceutical -2024 parent results
Feb 7 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2024 Dec 31, 2023 Dec 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 60.43 54.64 64.70
(+10.6 pct) (+11.7 pct) (+7.1 pct)
Operating 6.80 5.04 4.10
(+35.0 pct) (-9.1 pct) (-39.7 pct)
Recurring 6.93 5.31 4.50
(+30.5 pct) (-4.1 pct) (-35.0 pct)
Net 5.04 4.12 3.40
(+22.4 pct) (+4.4 pct) (-32.6 pct)
EPS 179.38 yen 146.60 yen 120.95 yen
Ann Div 120.00 yen 120.00 yen 120.00 yen
-Q2 Div 60.00 yen 50.00 yen 60.00 yen
-Q4 Div 60.00 yen 70.00 yen 60.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)